FEATURE
MHC CLASS I
MHC CLASS II
CLINICAL LINK
HLA-A, -B, -C
HLA-DP, -DQ, -DR
Chromosome 6p · codominant
All nucleated cells and platelets
APCs: DCs, macrophages, B cells (thymic epithelium)
RBCs lack MHC I → malaria can hide
α heavy chain + β2-microglobulin; closed groove (8–10 aa)
α + β chains; open groove (13–25 aa)
β2-microglobulin ↑ in myeloma, dialysis amyloid
Endogenous: cytosolic proteins, viruses, tumor antigens
Exogenous: phagocytosed microbes, extracellular proteins
—
Ubiquitin → proteasome → TAP transporter into ER → loaded on MHC I
Endosome/lysosome proteases; invariant chain (CLIP) removed by HLA-DM
TAP deficiency → low MHC I (bare lymphocyte type 1)
CD8⁺ cytotoxic T cell
CD4⁺ helper T cell
MHC II deficiency → no CD4⁺ cells
Yes — inhibitory KIRs read MHC I
No
Missing MHC I → NK killing
DCs load exogenous antigen onto MHC I
—
Basis of tumor and some vaccine immunity
—
Cross-link MHC II outside the groove with TCR Vβ → massive polyclonal T-cell activation
TSST-1, SpeA → toxic shock
HSV, CMV, adenovirus, HIV (nef) ↓ MHC I
—
Leaves cells open to NK killing
HLA-A, -B
HLA-DR (most important)
Each sibling: 25% chance of identical match